89bio Inc. (ETNB) Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
Go back to 89bio Inc. (ETNB) Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin
June 28, 2022 4:00 PM EDT
89bio Inc. (NASDAQ: ETNB) Halted, News Pending
...
More